Company Spotlight

Biosynth Carbosynth

4 Rietlistrasse,
Staad, SG 9422
Switzerland
View Profile

Cytovance Biologics

800 Research Pkwy., Suite 200
Oklahoma City, OK 73104
United States
View Profile

Quotient Sciences

3080 McCann Farm Drive
Garnet Valley, PA 19060
United States
View Profile


Contract Service Directory


Tri-Pac





Company Headquarters

3333 North Kenmore Street,
South Bend, IN 46628
United States

Other Locations


Company Description

Tri-Pac, Inc. is a turnkey CDMO specializing in development and filling of aerosols, bovs, liquids, foams, gels, pastes and tubes. Markets served include OTC, Medical Device, Rx & Prestige Beauty. Tri-Pac, Inc. facilities include multiple ISO 7 & 8 Cleanroom filling and blending suites for aerosol, liquid and tube filling. Certifications include ISO 13485, ISO 22716, WHO GMP, ISO 9001, ISO 14001 & Organic NOP/ANSI. Facility complies with US FDA, EPA, ITAR, Health Canada & REACH.

Contract Service Directory

    Related Content

    • Analytical Services | Bioanalytical Services | Biologics, Proteins, Vaccines | cGMP Manufacture | Drug Development | Formulation Development
      Contract Pharma’s 20th Anniversary Series: Ajinomoto Bio-Pharma

      Contract Pharma’s 20th Anniversary Series: Ajinomoto Bio-Pharma

      David Enloe of Ajinomoto Bio-Pharma Services shares his perspective on market changes over the years and the evolution of more integrated outsourcing
      Kristin Brooks, Contract Pharma 11.11.19

    • Breaking News | Industry News
      Alexion to Acquire Achillion in $930M Deal

      Alexion to Acquire Achillion in $930M Deal

      Will gain oral small molecule Factor D inhibitors to treat people with complement alternative pathway-mediated rare diseases
      10.18.19

    • Biologics, Proteins, Vaccines | Breaking News | Drug Development | Drug Discovery | Industry News
      Astellas to Fund Boston-Area Cell and Gene Therapy Start-Up

      Astellas to Fund Boston-Area Cell and Gene Therapy Start-Up

      Invests $12.5 million to support LabCentral Incubators in Boston's Life Science Community
      10.01.19



    • Bio News | Biologics, Proteins, Vaccines | Breaking News | Facilities | Industry News | Validation
      CMAB Receives Positive Opinion Following External Quality Audit

      CMAB Receives Positive Opinion Following External Quality Audit

      CDMO’s fully integrated facility in Suzhou, China was found to conform to EU Eudralex Vol. 4 GMP guidelines
      09.10.19

    • Formulation Development | Industry News
      Enteris, Cara Therapeutics Enter Peptelligence Pact

      Enteris, Cara Therapeutics Enter Peptelligence Pact

      Cara has a non-exclusive, royalty-bearing license to the Peptelligence technology to develop, manufacture and commercialize Oral KORSUVA
      08.26.19


    • Allergan

      Allergan

      ...
      07.15.19

    • Drug Development | Industry News
       Altimmune Signs Agreement to Acquire Spitfire Pharma

      Altimmune Signs Agreement to Acquire Spitfire Pharma

      Receives rights to NASH drug candidate, SP-1373
      07.09.19